IP Library Granted Patent US 6,927,041
Granted Patent B2
US 6,927,041 · App. 09/899,532 · Granted Aug 9, 2005

Human neuropeptide Y-like G protein-coupled receptor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,927,041
App. No.
09/899,532
Granted
Aug 9, 2005
Kind
B2
Abstract

Reagents which regulate human neuropeptide Y-like G protein-coupled receptor (NPY-like GPCR) protein and reagents which bind to human NPY-like GPCR gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, obesity, diabetes, anxiety, hypertension, cocaine withdrawal, congestive heart failure, memory enhancement, cardiac and cerebral vasospasm, pheochromocytoma, ganglioneuroblastoma, Huntington's disease, Alzheimer's disease, and Parkinson's disease.

Claims (9)

1. An isolated polynucleotide encoding a polypeptide that comprises the amino acid sequence shown in SEQ ID NO:2.

2. The isolated polynucleotide of claim 1 which comprises the nucleotide sequence shown in SEQ ID NO:1.

3. The isolated polynucleotide of claim 1 which consists of the nucleotide sequence shown in SEQ ID NO:1.

4. The isolated polynucleotide of claim 1 which is a cDNA molecule.

5. An expression vector comprising a polynucleotide that encodes a polypeptide comprising the amino acid sequence shown in SEQ ID NO:2.

6. The expression vector of claim 5 which comprises the nucleotide sequence shown in SEQ ID NO:1.

7. A host cell comprising an expression vector comprising a polynucleotide that encodes a polypeptide comprising the amino acid sequence shown in SEQ ID NO:2.

8. The host cell of claim 7 wherein the expression vector comprises the nucleotide sequence shown in SEQ ID NO:1.

9. A method of producing a polypeptide comprising the amino acid sequence shown in SEQ ID NO:2, comprising the steps of: culturing a host cell comprising an expression vector that comprises the nucleotide sequence shown in SEQ ID NO:1 under conditions whereby the polypeptide is expressed; and isolating the polypeptide.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2011
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: PERKINELMER BIOSIGNAL, INC
Reel/Frame 026521/0645 →
NUNC PRO TUNC ASSIGNMENT Recorded Jan 27, 2010
From: BAYER CORPORATION
To: BAYER PHARMACEUTICALS CORPORATION
Reel/Frame 023854/0934 →
MERGER Recorded Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →
NUNC PRO TUNC ASSIGNMENT Recorded Dec 4, 2009
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE AG
Reel/Frame 023605/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2001
From: BLOOMQUIST, BRIAN; ZHELNIN, LEONID
To: BAYER CORPORATION
Reel/Frame 012314/0723 →